These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 34001239)

  • 21. Circulating tumour DNA as a biomarker in resectable and irresectable stage IV colorectal cancer; a systematic review and meta-analysis.
    Jones RP; Pugh SA; Graham J; Primrose JN; Barriuso J
    Eur J Cancer; 2021 Feb; 144():368-381. PubMed ID: 33422803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating tumor DNA sequencing for colorectal cancers: A comparative analysis of colon cancer and rectal cancer data.
    Huang K; Qu H; Zhang X; Huang T; Sun X; He W; Li M; Lin L; Xu M; Chen S; Xia L
    Cancer Biomark; 2019; 26(3):313-322. PubMed ID: 31561327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of liquid biopsies in colorectal cancer.
    Wills B; Gorse E; Lee V
    Curr Probl Cancer; 2018 Nov; 42(6):593-600. PubMed ID: 30268335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Circulating Tumor DNA Among Patients with Colorectal Peritoneal Metastases.
    Baumgartner JM; Botta GP
    J Gastrointest Cancer; 2024 Mar; 55(1):41-46. PubMed ID: 37436640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylated circulating tumor DNA in hepatocellular carcinoma: A comprehensive analysis of biomarker potential and clinical implications.
    Zhu Q; Xie J; Mei W; Zeng C
    Cancer Treat Rev; 2024 Jul; 128():102763. PubMed ID: 38763055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Profiling Colorectal Cancer in the Landscape Personalized Testing-Advantages of Liquid Biopsy.
    Verbanac D; Čeri A; Hlapčić I; Shakibaei M; Brockmueller A; Krušlin B; Ljubičić N; Baršić N; Detel D; Batičić L; Rumora L; Somborac-Bačura A; Štefanović M; Ćelap I; Demirović A; Petlevski R; Petrik J; Grdić Rajković M; Hulina-Tomašković A; Rako I; Saso L; Barišić K
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating biomarkers for early detection and clinical management of colorectal cancer.
    Marcuello M; Vymetalkova V; Neves RPL; Duran-Sanchon S; Vedeld HM; Tham E; van Dalum G; Flügen G; Garcia-Barberan V; Fijneman RJ; Castells A; Vodicka P; Lind GE; Stoecklein NH; Heitzer E; Gironella M
    Mol Aspects Med; 2019 Oct; 69():107-122. PubMed ID: 31189073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colorectal cancer detected by liquid biopsy 2 years prior to clinical diagnosis in the HUNT study.
    Brenne SS; Madsen PH; Pedersen IS; Hveem K; Skorpen F; Krarup HB; Giskeødegård GF; Laugsand EA
    Br J Cancer; 2023 Sep; 129(5):861-868. PubMed ID: 37438612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating tumor DNA detectable in early- and late-stage colorectal cancer patients.
    Yang YC; Wang D; Jin L; Yao HW; Zhang JH; Wang J; Zhao XM; Shen CY; Chen W; Wang XL; Shi R; Chen SY; Zhang ZT
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29914973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. O6-Methyguanine-DNA Methyl Transferase (MGMT) Promoter Methylation in Serum DNA of Iranian Patients with Colorectal Cancer.
    Alizadeh Naini M; Kavousipour S; Hasanzarini M; Nasrollah A; Monabati A; Mokarram P
    Asian Pac J Cancer Prev; 2018 May; 19(5):1223-1227. PubMed ID: 29801405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer.
    Narayan RR; Goldman DA; Gonen M; Reichel J; Huberman KH; Raj S; Viale A; Kemeny NE; Allen PJ; Balachandran VP; D'Angelica MI; DeMatteo RP; Drebin JA; Jarnagin WR; Kingham TP
    Ann Surg Oncol; 2019 Jun; 26(6):1824-1832. PubMed ID: 30706231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A feasibility study of colorectal cancer diagnosis via circulating tumor DNA derived CNV detection.
    Molparia B; Oliveira G; Wagner JL; Spencer EG; Torkamani A
    PLoS One; 2018; 13(5):e0196826. PubMed ID: 29791457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating Tumor DNA: Towards More Individualized Treatment for Patients with Resectable Colorectal Cancer.
    Adams AM; Vreeland TJ; Newhook TE
    J Gastrointest Cancer; 2023 Dec; 54(4):1071-1081. PubMed ID: 36562938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of circulating tumor DNA in the management of patients with colorectal cancer.
    Moati E; Taly V; Didelot A; Perkins G; Blons H; Taieb J; Laurent-Puig P; Zaanan A
    Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):396-402. PubMed ID: 29627453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular biomarkers in the diagnostic of patients with colorectal cancer.
    Fabišíková K; Behulová RL; Repiska V
    Neuro Endocrinol Lett; 2019 Dec; 40(5):215-221. PubMed ID: 32112545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perspectives of the Application of Liquid Biopsy in Colorectal Cancer.
    Ding Y; Li W; Wang K; Xu C; Hao M; Ding L
    Biomed Res Int; 2020; 2020():6843180. PubMed ID: 32258135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer.
    Kidess-Sigal E; Liu HE; Triboulet MM; Che J; Ramani VC; Visser BC; Poultsides GA; Longacre TA; Marziali A; Vysotskaia V; Wiggin M; Heirich K; Hanft V; Keilholz U; Tinhofer I; Norton JA; Lee M; Sollier-Christen E; Jeffrey SS
    Oncotarget; 2016 Dec; 7(51):85349-85364. PubMed ID: 27863403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of Multiplex Bisulfite PCR-Ligase Detection Reaction-Real-Time Quantitative PCR Assay in Interrogating Bioinformatically Identified, Blood-Based Methylation Markers for Colorectal Cancer.
    Bacolod MD; Mirza AH; Huang J; Giardina SF; Feinberg PB; Soper SA; Barany F
    J Mol Diagn; 2020 Jul; 22(7):885-900. PubMed ID: 32407802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of postoperative follow-up of patients with metastatic colorectal cancer using circulating tumor DNA.
    Benešová L; Hálková T; Ptáčková R; Semyakina A; Menclová K; Pudil J; Ryska M; Levý M; Šimša J; Pazdírek F; Hoch J; Blaha M; Minárik M
    World J Gastroenterol; 2019 Dec; 25(48):6939-6948. PubMed ID: 31908397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patients.
    Hallermayr A; Wohlfrom T; Steinke-Lange V; Benet-Pagès A; Scharf F; Heitzer E; Mansmann U; Haberl C; de Wit M; Vogelsang H; Rentsch M; Holinski-Feder E; Pickl JMA
    J Hematol Oncol; 2022 Sep; 15(1):125. PubMed ID: 36056434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.